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Abstract 
Was a comprehensive analysis of combined influence of the gene polymorphisms 
associated with various links in the regulation of apoptosis (BCL-2, CTLA-4 and APO-1 / 
Fas) on the development of nodular goiter on the background of autoimmune thyroiditis and 
thyroid adenoma in the surveyed population with regard to changes in the functional activity 
of the thyroid gland and the degree of the thyroid gland enlargement has been performed. For 
this purpose, we used the method of Multifactor Dimensions Reduction 3.0.2 – MDR by 
calculating the prediction potentials. 
Established that graphic models of gene-gene interaction with the highest cross-
validation consistency created by Multifactor Dimensions Reduction 3.0.2 – MDR method, 
showed complex "synergistic or independent" impact of polymorphic loci of the CTLA-4 (+ 
49G / A), Fas (-1377G / A) and Bcl-2 (63291411A> G) genes on the onset of the change of 
thyroid function and degree of hyperplasia in the population of residents of Northern 
Bukovina. 
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Key words: nodular goiter, autoimmune thyroiditis, thyroid adenoma, APO-1 / 
FAS, CTLA-4 and BCL-2 genes interaction. 
 
Abbreviations: NGAIT - nodular goiter with autoimmune thyroiditis, AIT- 
autoimmune thyroiditis, TG - thyroid gland, TA - thyroid adenoma. 
 
Introduction 
The etiology of Hashimoto’s thyroiditis is considered to be multifactorial, involving 
the interplay of various environmental and genetic factors. Studies conducted on the genetic 
associations of Hashimoto’s thyroiditis have shown that the human leukocyte antigen (HLA) 
region, which plays a major role in other autoimmune disorders, is associated with 
development of Hashimoto’s thyroiditis [1-5].  
Defects in genes that play an important role in thyroid physiology and thyroid 
hormone synthesis could predispose to the development of goiter, especially in case of 
borderline or overt iodine deficiency. Such defects could lead to dyshormonogenesis as an 
immediate response, thereby indirectly explaining the nodular transformation of the thyroid as 
late consequences of dyshormonogenesis, as a form of maladaptation [6, 7]. The genes that 
encode the proteins involved in thyroid hormone synthesis, such as the thyroglobulin-gene 
(TG-gene), the thyroid peroxidase-gene (TPO-gene), the sodium – iodide – symporter-gene 
(SLC5A5), the Pandered syndrome-gene (SLC26A4), the TSH receptor-gene (TSH-R-gene), 
the iodothyronine deiodinase (DEHAL 1) and the thyroid oxidase 2 gene3 (DUOX2) are 
convincing candidate genes in familial euthyroid goiter [6]. Originally, several mutations in 
these genes were identified in patients with congenital hypothyroidism [7]. However, in cases 
of less severe functional impairment, with can still be compensated, a contribution of variants 
of these genes in the etiology of nontoxic goiter is possible. 
The genetic predisposition to the development of AIT is confirmed by its association 
with certain antigens of the HLA system, but it should be noted that the antigens of the HLA 
system are markers of a number of autoimmune diseases, so they cannot be considered as a 
specific "disease gene" [8-11]. One can only talk about the innate propensity to a certain type 
of autoimmune reactions. Many studies have been conducted to find associations between 
autoimmune CHD diseases and a multitude of immune response loci, including the HLA 
region on the chromosome 6p21, the CTLA4 region on the chromosome 2q33, and the 
PTPN22 region on the chromosome 1 p1 [12-16]. 
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The next step of our study was the comprehensive analysis of combined influence of 
the gene polymorphisms associated with various links in the regulation of apoptosis (BCL-2, 
CTLA-4 and APO-1 / Fas) on the functional activity changes (normal function, subclinical 
and clinical hypothyroidism) and TG hyperplasia degrees (IB, II and III) in the surveyed 
population. For this purpose, we used the method of Multifactor Dimensions Reduction 3.0.2 
– MDR by calculating the prediction potentials.  
Material and methods 
95 women with NGAIT were examined in 2013- 2016 in Chernivtsi regional clinical 
hospital. The age of patients ranged from 23 to 72 years. The diagnosis was made clinically, 
in laboratory (thyroid peroxidase antibodies (TPAB) - 60-250 U / ml thyroglobulin antibodies 
(TGAB) - 60-500 U / ml; thyroid-stimulating hormone (TSH) - 4.10 mU / L), using 
ultrasound and it was confirmed histologically after the surgery.  
We singled out a group of 30 women who had been diagnosed with thyroid adenoma 
after the surgery by ultrasound, fine-needle aspiration biopsy (FNAB) and histological 
conclusion. The group was identified due to the fact that this pathology is one of the most 
common forms of nodular goiter. These indicators served as controls. The final confirmation 
of morphologically unchanged tissue was obtained after the histological conclusion. 
The TG functional activity changes (normal function, subclinical and clinical 
hypothyroidism). The diagnosis is confirmed biochemically by a reduction in serum free T4 
with increased serum thyroid-stimulating hormone (TSH; thyrotropin). Subclinical 
hypothyroidism is a biochemical diagnosis and describes an elevated serum TSH with normal 
free thyroid hormones. Hypothyroidism is treated by T4 replacement, the aims of treatment 
being relief of symptoms and restoration of serum TSH to the reference range. 
TG hyperplasia degrees (I and II) were analyzed according to the World Health 
Organization (WHO) classification: 
Grade 0: No goiter is palpable or visible. 
I degree: palpable goiter, not visible when neck is held in normal position  
II degree: a clearly swollen neck (also visible in normal position of the neck) that is 
consistent with a goiter on palpation. 
25 practically healthy donors were examined as well. 10 ml of the peripheral blood 
drawn from the ulnar vein in the morning on an empty stomach served as the material for the 
study. 
All the patients underwent a surgery. The range of surgical intervention – from 
hemithyroidectomy to thyroidectomy.  
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The DNA was isolated by means of a set of reagents Thermo Scientific Gene JET 
Genomic DNA Purification kit (# K0721, Thermo Fisher Scientific), according to the 
directions for use, with incubation with proteinase K overnight to complete cell lysis. The 
purified DNA was diluted in Elution Buffer and evaluated with a spectrophotometer 
Nanodrop2000C. Only samples with a concentration of not lower than 15 ng / ml and the 
values of the ratio of A (260/280) between 1.7 and 2.0 were used for genotyping. The 
obtained extracts were divided into aliquots, one of which was placed in a refrigerator at 4oC 
until its use, while others were frozen at -20oC. 
To normalize the amount of DNA, all samples were brought to a concentration of 2 ng 
/ µL using Nuclease-free water.  
To genotype the selected point polymorphism, the TaqMan technology was used. 
Polymorphisms marked with the reference number SNP ID, according to the database dbSNP 
have been studied. To test each of the polymorphisms TaqMan® SN Genotyping Assays 
(40X) (4,351,379, Thermo Fisher Scientific) were used (table 1)    
               
 Table 1 
The nucleotide sequence of the region including the analyzed 
polymorphism 
Reference 
number SNP ID 
Test number 
(Assay ID*) 
Fragment of the region including the analyzed 
polymorphism 
rs231775 
(CTLA4) 
C_2415786_20 GCACAAGGCTCAGCTGAACCTGGCT[A/G]CCA
GGACCTGGCCCTGCACTCTCCT 
rs17759659 
(BCL2) 
C_33628167_10 TCTTCTTACCAAAGATTCACAATAC[A/G]GTGT
TGATGGGAACGTGACCTAGTT 
rs2234767 
(FAS) 
C_12123966_10 CAGAGTGTGTGCACAAGGCTGGCAC[A/G]CCC
AGGGTCTTCCTCATGGCACTAA 
Note: according to the website www.thermofisher.com. 
 
The volume of the reaction mixture was 5 µL and consisted of: 2.5 µL reagent Taq 
Man Genotyping Master Mix (20X) (4,371,355, Thermo Fisher Scientific), 0,25 µL of probe 
solution and 2.25 µL of DNA solution. Genotyping was performed with the instrument Quant 
Studio 6 (Applied Biosystems, Thermo Fisher Scientific), 384-well block. 
Amplification was performed under the following conditions: 
Activation 10 min 95oC  
Denaturation 15 sec 92oC 40*/60** 
cycles Annealing / elongation 1 min 60oC 
Note: * - to amplify the polymorphisms associated with CTLA-4 and Fas genes;  
** - to amplify the polymorphisms associated with Bcl-2 genes. 
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To collect and process the data the software Quant Studio™ Real-Time PCR (v.1.3) 
was used.  
The main part of the statistical analysis was carried out using the software «Statistica 
7.0» (SPSS). Nominal data are presented in the form of quantitative values and percentages. 
The balance Hardy - Weinberg of the genotype distribution was checked using Online 
Encyclopedia for Genetic Epidemiology Studies (http://www.oege.org/software/hwe-mr-
calc.shtml). To compare the distribution of genotypes in the experimental and control groups 
Pearson's chi-squared test was used. The reliability of differences of averages in groups with 
different genotypes was determined by the method of univariate analysis of variance 
(ANOVA). The impact of factors on the development of thyroid pathology was assessed 
using a binary logistic regression model for the relative risk (RelR), risk ratio (RR) and odds 
ratio (OR) with 95% confidence interval [95% CI], taking into account the criterion 2 (df = 
1). The difference was considered reliable at p <0.05. 
Results and discussion 
The best models of gene-gene interaction including those, where the TG function and 
the degree of its enlargement with the highest rates of cross-validation consistency are taken 
into account, are shown in table 2. 
The method of multifactor dimension reduction (MDR) showed the reliability and a 
high reproducibility of a single-factor model with CTLA-4 gene involvement (table 2), both 
in the whole surveyed population of patients with risk of thyroid pathology persisted in one-
component model involving the CTLA-4 gene as in euthyroidism (80% reproducibility, 
accuracy 69,27%, OR = 16,0; p = 0.015), somewhat stronger in subclinical and clinical 
hypothyroidism (100 % and 80% reproducibility, OR = 31,0; p <0.001 and OR = 9,17; p = 
0.043, respectively) and the second degree thyroid hyperplasia (100% reproducibility, OR = 
6,37; p = 0.022). 
In addition, this two-component model (CTLA-4 and Fas) proved to be effective for 
subclinical hypothyroidism (with the highest accuracy 97,41%; OR = 16,33; p <0.001) and 
the I-degree thyroid hyperplasia (OR = 4,36; p = 0.049). The two-component model which 
involved the BCL-2 and CTLA-4 genes also confirmed its classification ability in the forecast 
of the II-degree thyroid hyperplasia (100% reproducibility; OR = 12,0; p = 0.032).  
Graphic models of gene-gene interactions in thyroid pathology in the surveyed 
population (figures 1-3) show a high probability of euthyroidism with minor G-allele of the 
CTLA-4 and Bcl-2 (0,452 і 0,785 respectively) in the combination, which increases when AG-
genotype of the Fas gene (1,452) is added to the combination.  
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Table 2 
Models of gene-gene interactions among the surveyed individuals in general and 
considering thyroid gland pathology, the TG function and the degree of its enlargement 
Groups 
Combinations 
of genes in 
prognostic 
models 
Model 
reproduc
ibility  
Testing 
cross-
validation 
consistency  
Model 
accuracy 
% 
OR; р 
euthyroidi
sm 
CTLA-4 8/10 4,26 69,27 OR=16,0; р=0,015 
BCL-2, CTLA-
4 
9/10 4,66 54,87 OR=2,71; р>0,05 
BCL-2, CTLA-
4, Fas 
10/10 5,51 58,65 OR=2,65; р>0,05 
Subclinica
l 
hypothyroi
dism 
CTLA-4 10/10 12,79 72,53 OR=31,0; р<0,001 
CTLA-4, Fas 7/10 12,64 97,41 OR=16,33; р<0,001 
BCL-2, CTLA-
4, Fas 
10/10 13,23 55,57 OR=3,12; р>0,05 
Clinical 
hypothyroi
dism 
CTLA-4 8/10 5,24 72,24 OR=9,17; р=0,043 
BCL-2, CTLA-
4 
8/10 4,63 64,60 OR=2,80; р>0,05 
BCL-2, CTLA-
4, Fas 
10/10 9,69 56,96 OR=1,29; р>0,05 
I degree 
thyroid 
hyperplasi
a 
CTLA-4 10/10 4,95 74,78 OR=6,37; р=0,022 
CTLA-4, Fas 10/10 17,33 48,21 OR=4,36; р=0,049 
BCL-2, CTLA-
4, Fas 
10/10 17,33 77,71 OR=1,17; р>0,05 
II degree 
thyroid 
hyperplasi
a  
Fas 5/10 2,79 51,47 OR=2,77; р>0,05 
BCL-2, CTLA-
4 
10/10 4,35 63,91 OR=12,0; р=0,032 
BCL-2, CTLA-
4, Fas 
10/10 4,35 61,24 OR=2,0; р>0,05 
Note. TA – thyroid adenoma; АІТ – autoimmune thyroiditis; TG – thyroid gland; OR -
Odds Ratio. 
 
The lowest probability of euthyroidism in thyroid pathology was observed in case of 
coincidence of wild alleles in the homozygous state of the three genes (-1.548) (fig. 3). 
 
 612 
       
Fig. 1. Polymorphic variants of the 
CTLA-4 gene (+49G/A), causing a high 
(dark grey box) and a low (light grey 
box) probability of euthyroidism in 
patients. Note: 0, 1, 2 – polymorphic 
variants of the CTLA-4 gene- АА (0), 
AG (1), GG (2) 
 Fig. 2. Combination of polymorphic variants 
of CTLA-4 (+49G/A) and BCL-2 
(63291411A>G) genes, causing a high (dark 
grey box) and a low (light grey box) 
probability of euthyroidism in thyroid 
pathology in patients. Note: CTLA-4 0, 1, 2 – 
polymorphic variants of the CTLA-4 gene АА 
(0), AG (1), GG (2); 0, 1, 2 Bcl-2 - 0, 1 – 
polymorphic variants of the Bcl-2 gene АА 
(0), AG (1), GG (2). The white boxes mean 
the absence of the combinations of the gene 
genotypes.  
 
Fig. 3. Combination of polymorphic variants of CTLA-4 (+49G/A), Fas (-1377G/A) 
and BCL-2 (63291411A>G) genes, causing a high (dark grey box) and a low (light grey box) 
probability of euthyroidism in thyroid pathology in patients. Note: CTLA-4 0, 1, 2 – 
polymorphic variants of the CTLA-4 gene АА (0), AG (1), GG (2); Fas 0, 1 – polymorphic 
variants of the Fas GG (0) gene, AG (1); 0, 1, 2 Bcl-2 – polymorphic variants of the Bcl-2 
gene АА (0), AG (1), GG (2). The white boxes mean the absence of the combinations of the 
gene genotypes. 
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Analyzing the association of the gene polymorphic site with the condition of 
euthyroidism in patients suffering from thyroid pathology according to the entropy index 
showed that +49G/A polymorphic locus of the CTLA-4 gene was the most influential 
(21,58%) (fig. 4). This effect was amplified with synergistic interaction with polymorphic site 
of the Bcl-2 gene (63291411A> G) by 3.74%. The effects of polymorphisms of Bcl-2 
(rs17759659) and Fas (rs2234767) genes on euthyroidism onset in thyroid pathology were 
independent with entropy share 3,53% and 8,86% respectively.   
 
 
Fig. 4. Cluster analysis of modeling gene-gene interaction of three genes CTLA-4, Fas 
and Bcl-2 in patients with thyroid pathology in the condition of euthyroidism. The synergistic 
interaction is marked in orange, the independent impact is in green and blue. 
 
In patients with thyroid pathology (fig. 5, 6) two-locus model involving AG-genotype 
(of Fas gene) and G-allele (of CTLA-4 gene) and three-locus model involving AG-genotype 
(of Fas & Bcl-2 genes) and G-allele (of CTLA-4 gene) proved to be the best ones and 
increased the risk of subclinical hypothyroidism in the population of Northern Bukovina 
residents (1,115 and 1,282 respectively).  
The risk of clinical hypothyroidism in thyroid pathology (fig. 7, 8) is the highest with 
three-locus combination of AG-genotype of the CTLA-4 & Fas & Bcl-2 genes (1,435), the 
two-locus model involving AG-genotype (of the CTLA-4 and Bcl-2 genes) proved to be 
weaker (0,685).  
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Fig. 5. Polymorphic variants of the 
CTLA-4 (+49G/A) and Fas (-
1377G/A) genes, causing a high 
(dark grey box) and a low (light 
grey box) risk of subclinical 
hypothyroidism in thyroid 
pathology in patients. Note: 0, 1, 2 
– polymorphic variants of the 
CTLA-4 gene- АА (0), AG (1), GG 
(2); Fas 0, 1 – polymorphic 
variants of the Fas GG (0) gene, 
AG (1). 
 Fig. 6. Combination of polymorphic variants of 
the CTLA-4 (+49G/A), Fas (-1377G/A) and Bcl-2 
(63291411A>G) genes, causing a high (dark grey 
box) and a low (light grey box) risk of subclinical 
hypothyroidism in thyroid pathology in patients. 
Note: CTLA-4 0, 1, 2 – polymorphic variants of 
the CTLA-4 gene АА (0), AG (1), GG (2); Fas 0, 1 
– polymorphic variants of the Fas gene GG (0), 
AG (1); 0, 1, 2 Bcl-2 – polymorphic variants of the 
Bcl-2 gene АА (0), AG (1), GG (2). The white 
boxes mean the absence of the combinations of 
the gene genotypes. 
 
         
Fig. 7. Polymorphic variants of the 
CTLA-4 (+49G/A) and BCL-2 
(63291411A>G) genes, cussing a 
high (dark grey box) and a low 
(light grey box) risk of clinical 
hypothyroidism in thyroid 
pathology in patients. Note: 0, 1 – 
polymorphic variants of the CTLA-
4 gene- АА (0), AG (1); 0, 1, 2 Bcl-
2 – polymorphic variants of the 
Bcl-2 gene АА (0), AG (1), GG (2). 
The white boxes mean the absence 
of the combinations of the gene 
genotypes. 
 Fig. 8. Combination of polymorphic variants of 
the CTLA-4 (+49G/A), Fas (-1377G/A) and Bcl-2 
(63291411A>G) genes, causing a high (dark grey 
box) and a low (light grey box) risk of clinical 
hypothyroidism in thyroid pathology in patients. 
Note: CTLA-4 0, 1, – polymorphic variants of the 
CTLA-4 gene АА (0), AG (1); Fas 0, 1 – 
polymorphic variants of the Fas gene GG (0), AG 
(1); 0, 1, 2 Bcl-2 – polymorphic variants of the 
Bcl-2 gene АА (0), AG (1), GG (2). The white 
boxes mean the absence of the combinations of 
the gene genotypes.  
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According to the results of cluster analysis of modeling gene-gene interaction in 
subclinical and clinical hypothyroidism the highest share of entropy belonged to 
polymorphism of the CTLA-4 (+49G/A) and Fas (-1377G/A) genes: 30,56% and 20,55% (fig. 
9) and 13,67% and 6,17% (fig. 10), respectively. An independent connection between 
polymorphic loci of genes was found in subclinical hypothyroidism (from -13,05% to -1,61%) 
and synergistic one between polymorphic sites of the CTLA-4 (+49G/A) and Bcl-2 
(63291411A>G) genes, which increased the risk of clinical hypothyroidism by 7,43% in the 
population (fig. 10).  
 
  
            
Fig. 9. Cluster analysis of modeling gene-
gene interaction of three genes CTLA-4, 
Fas and Bcl-2 in patients with thyroid 
pathology in the condition of subclinical 
hypothyroidism. The independent effect is 
marked in green, brown and blue.  
Fig. 10. Cluster analysis of modeling gene-
gene interaction of three genes CTLA-4, 
Fas and Bcl-2 in patients with thyroid 
pathology in the condition of clinical 
hypothyroidism. The synergistic interaction 
is marked in red while the independent 
effect is in green and brown.  
 
The risk of the І-degree thyroid hyperplasia in AIT and TA (fig. 11, 12) is the highest 
in three-locus combination of AG-genotype of the CTLA-4 & Fas & Bcl-2 genes (1,025; 
р>0,05), the two-locus model involving AG- genotype of the CTLA-4 & Fas genes is 
somewhat weaker but reliable (0,882; р=0,049). The lowest is the risk of the І-degree thyroid 
hyperplasia in combination of wild alleles in the homozygous state of the CTLA-4 & Fas 
genes (-0,975). 
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Fig. 11. Polymorphic variants of 
the CTLA-4 (+49G/A) and Fas (-
1377G/A) genes, causing a high 
(dark grey box) and a low (light 
grey box) risk of І-degree thyroid 
hyperplasia in patients. Note: 0, 1 
CTLA-4  – polymorphic variants of 
the CTLA-4 gene - АА (0), AG (1); 
0, 1 Fas – polymorphic variants of 
the Fas GG (0) gene, AG (1). 
 Fig. 12. Combination of polymorphic variants of 
the CTLA-4 (+49G/A), Fas (-1377G/A) and Bcl-2 
(63291411A>G) genes, causing a high (dark grey 
box) and a low (light grey box) risk of I-degree 
thyroid hyperplasia in patients. Note: CTLA-4 0, 
1, – polymorphic variants of the CTLA-4 gene АА 
(0), AG (1); Fas 0, 1 – polymorphic variants of the 
Fas gene GG (0), AG (1); 0, 1, 2 Bcl-2 – 
polymorphic variants of the Bcl-2 gene АА (0), 
AG (1), GG (2). The white boxes mean the 
absence of the combinations of the gene 
genotypes. 
 
The risk of the ІI-degree thyroid hyperplasia in AIT and TA (fig. 13, 14) increases 
statistically significantly in two-locus combination of AG-genotype of the CTLA-4 & Bcl-2 
genes (1,038; р=0,032). The three-locus model of gene-gene interaction involving AG-
genotype of the three CTLA-4 & Fas & Bcl-2 genes proved to be stronger but unreliable 
(1,538). The lowest risk of I-degree thyroid hyperplasia was in the combination of wild alleles 
in homozygous state of both two genes CTLA-4 & Bcl-2 (-1,462), and in combination of three 
genes CTLA-4 & Bcl-2& Fas (-1,462). 
Cluster analysis of gene-gene interaction in I-degree thyroid hyperplasia (fig. 15) 
indicated the synergistic interconnection between polymorphic sites of the CTLA-4 and Fas 
genes with the highest entropy rate (10,07% and 7,15%), whereas in ІI-degree thyroid 
hyperplasia (fig. 16) – between polymorphic loci of the CTLA-4 and Bcl-2 genes (21,97% and 
5,82% respectively). The entropy rate in the latter case was higher for gene Fas (10,47%), 
whose polymorphism influenced independently the onset of the ІI-degree thyroid hyperplasia 
in the population of surveyed residents of Bukovina (neutralizing effect on the impact of 
polymorphic site of the CTLA-4 gene was minus 11.53%; p> 0.05). 
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Fig. 13. Polymorphic variants of 
the CTLA-4 (+49G/A) and BCL-2 
(63291411A>G) genes, cussing a 
high (dark grey box) and a low 
(light grey box) risk of the ІI-
degree thyroid hyperplasia in 
patients. Note: 0, 1, 2 – 
polymorphic variants of the CTLA-
4 gene- АА (0), AG (1) GG (2); 0, 
1, 2 Bcl-2 – polymorphic variants 
of the Bcl-2 gene АА (0), AG (1), 
GG (2).  
 Fig. 14. Combination of polymorphic variants of 
the CTLA-4 (+49G/A), Fas (-1377G/A) and Bcl-2 
(63291411A>G) genes, causing a high (dark grey 
box) and a low (light grey box) risk of ІI-degree 
thyroid hyperplasia in patients. Note: CTLA-4 0, 
1, 2– polymorphic variants of the CTLA-4 gene 
АА (0), AG (1), GG (2); Fas 0, 1 – polymorphic 
variants of the Fas gene GG (0), AG (1); 0, 1, 2 
Bcl-2 – polymorphic variants of the Bcl-2 gene 
АА (0), AG (1), GG (2). The white boxes mean 
the absence of the combinations of the gene 
genotypes.  
 
      
Fig. 15. Cluster analysis of modeling the 
gene-gen interaction of three genes: CTLA-
4, Fas and Bcl-2 in patients with I-degree 
thyroid hyperplasia. 
Fig. 16. Cluster analysis of modeling the 
gene-gen interaction of three genes: CTLA-
4, Fas and Bcl-2 in patients with ІI-degree 
hyperplasia.  
Note. The synergistic interaction is marked in orange, the independent effect is in blue and 
brown. 
 
Conclusions: Graphic models of gene-gene interaction with the highest cross-
validation consistency created by Multifactor Dimension Reduction 3.0.2 – MDR method, 
showed complex "synergistic or independent" impact of polymorphic loci of the CTLA-4 (+ 
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49G / A), Fas (-1377G / A) and Bcl-2 (63291411A> G) genes on the onset of the change of 
thyroid function and degree of hyperplasia in the population of residents of Northern 
Bukovina. 
The classification ability of the created models, despite the high reproducibility (60-
100%), confirmed the likelihood of risks for a single-factor model involving the minor G-
allele of the CTLA-4 gene (especially of AG-genotype) as well as for two-locus model in the 
combination of AG-genotype of the CTLA-4 and Fas genes: onset of condition of 
euthyroidism (exclusively with the participation of CTLA-4 gene, subclinical hypothyroidism, 
clinical hypothyroidism, I-degree thyroid hyperplasia with the accuracy from 68,12% to 
97,41% and testing Cross-validation Consistency from 4,26 to 20,55, respectively. The two-
locus combination of AG-genotype of the CTLA-4 & Bcl-2 proved its effectiveness in the ІI-
degree thyroid hyperplasia prognosis.  
The three-component model involving three genes on the risk of thyroid pathology in 
the population in general CTLA-4 & Fas & Bcl-2 proved its classification capability. So did 
the combinations of:  
- AG-genotypes of three genes which associates with the risk euthyroidism (1,452), 
clinical hypothyroidism (1,435), I-degree thyroid hyperplasia (1,025) and that of the II-degree 
(1,538); 
- AG-genotypes of the Fas & Bcl-2 genes and G-allele of the CTLA-4 gene with the 
risk of АІТ (1,392) and subclinical hypothyroidism (1,282). 
Interlocus interaction in thyroid pathology is characterized by pronounced synergistic 
gene-gene relationship (CTLA-4 & Fas, CTLA-4 & Bcl-2 from 1,47% to 7,43%), or by 
independent, neutralizing effect (from -13,05% to 0,35%)  with the highest entropy rate which 
is typical for CTLA-4 gene (21,58% – in euthyroidism, 30,56% – in subclinical 
hypothyroidism, and 13,67% – in clinical hypothyroidism), which indicates its high 
contribution to the development of thyroid pathology both in general (21,38%), and of some 
of its nosology’s. Somewhat less significant (by 1,5-5,5 times) is the share in the development 
of thyroid pathology concerning the entropy rate made by the Fas gene (3,86%): 8,99% – in 
TA, 12,14% – in АІТ, 8,86% – in euthyroidism, 20,55% – in subclinical hypothyroidism, 
6,17% – in clinical hypothyroidism, respectively. 
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